Hepatitis C: The Impact of Hepatitis C Beyond the Liver
Wednesday, April 5, 2017, 2-3pm, EDT
Sponsored by Abbvie
It is known that Hepatitis C is a progressive liver disease that can lead to advanced fibrosis, cirrhosis, and hepatocellular carcinoma. What is less understood is that patients infected with the Hepatitis C virus are at an increased risk for other diseases such as renal disease, cardiovascular disorders, and Type 2 Diabetes. It is important that managed care professionals understand the impact that the Hepatitis C virus has not only on the liver, but also on other organ systems.
This educational webinar will explorer the available information on this topic and answer the following questions:
- What extrahepatic manifestations are associated with HCV?
- What is the pathophysiology behind extrahepatic manifestations?
- What risk do HCV infected patients have of developing specific extrahepatic manifestations?
- What is the cost associated with extrahepatic manifestations?
Joseph K. Lim, MD
Associate Professor of Medicine (Digestive Diseases)
Director, Yale Viral Hepatitis Program
This webinar is sponsored, developed and presented by the sponsor. The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy.
** IMPORTANT: AMCP webinars are limited to the first 500 that join the webinar. However, AMCP will provide a link to the recording and slides to all registrants within a week from the webinar date. The recording and slides of sponsored webinars will be provided if permitted by the sponsor.